Clinical Trial Update: Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant platinum-based chemotherapy for resectable non-small cell lung cancer with switch to an alternative chemotherapy regimen in nonresponders (N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-09